Parkman Healthcare Partners
Latest statistics and disclosures from Parkman Healthcare Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SYK, DXCM, Kalvista Pharmaceuticals, PODD, LLY, and represent 20.19% of Parkman Healthcare Partners's stock portfolio.
- Added to shares of these 10 stocks: LLY (+$32M), QGEN (+$20M), XENE (+$20M), PTCT (+$19M), NVST (+$18M), ABBV (+$16M), SYK (+$16M), ILMN (+$14M), ZBH (+$11M), ANIP (+$10M).
- Started 18 new stock positions in IRTC, SUPN, ABBV, TNGX, QGEN, Moderna Inc put, COGT, MMED, VIR, DRUG. IDXX, ERAS, PLSE, LLY, AMRX, ILMN, CARL, NVST.
- Reduced shares in these 10 stocks: Masimo Corporation (-$26M), TERN (-$25M), Qiagen Nv (-$22M), , MCK (-$21M), KNSA (-$20M), MTD (-$15M), , DHR (-$14M), .
- Sold out of its positions in ACHC, SYRE, A, FOLD, ACLX, BIIB, CERT, CRNX, DHR, DAWN.
- Parkman Healthcare Partners was a net buyer of stock by $19M.
- Parkman Healthcare Partners has $970M in assets under management (AUM), dropping by -7.69%.
- Central Index Key (CIK): 0001777015
Tip: Access up to 7 years of quarterly data
Positions held by Parkman Healthcare Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Parkman Healthcare Partners
Parkman Healthcare Partners holds 90 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Stryker Corporation (SYK) | 5.2 | $51M | +46% | 155k | 328.59 |
|
| Dex (DXCM) | 4.5 | $43M | +17% | 690k | 62.80 |
|
| Kalvista Pharmaceuticals | 3.8 | $37M | +3% | 1.8M | 20.13 |
|
| Insulet Corporation (PODD) | 3.4 | $33M | +11% | 157k | 209.84 |
|
| Eli Lilly & Co. (LLY) | 3.3 | $32M | NEW | 35k | 919.77 |
|
| Ptc Therapeutics I (PTCT) | 3.0 | $29M | +169% | 431k | 68.13 |
|
| Xenon Pharmaceuticals (XENE) | 3.0 | $29M | +222% | 497k | 58.15 |
|
| Boston Scientific Corporation (BSX) | 2.9 | $28M | -10% | 449k | 62.75 |
|
| CVS Caremark Corporation (CVS) | 2.9 | $28M | -13% | 387k | 71.82 |
|
| Arcus Biosciences Incorporated (RCUS) | 2.7 | $26M | +24% | 1.2M | 21.60 |
|
| Livanova SHS (LIVN) | 2.6 | $26M | 404k | 63.56 |
|
|
| Zimmer Holdings (ZBH) | 2.5 | $24M | +78% | 270k | 90.42 |
|
| Mbx Biosciences (MBX) | 2.5 | $24M | -9% | 800k | 29.85 |
|
| Biosante Pharmaceuticals (ANIP) | 2.2 | $22M | +93% | 281k | 76.90 |
|
| Syndax Pharmaceuticals (SNDX) | 2.2 | $21M | +57% | 902k | 23.36 |
|
| Qiagen Nv Ord Shares (QGEN) | 2.1 | $20M | NEW | 500k | 40.04 |
|
| Envista Hldgs Corp (NVST) | 1.9 | $18M | NEW | 712k | 25.37 |
|
| Eyepoint Com New (EYPT) | 1.8 | $18M | +24% | 1.4M | 12.89 |
|
| Abbvie (ABBV) | 1.7 | $16M | NEW | 75k | 217.49 |
|
| BioCryst Pharmaceuticals (BCRX) | 1.7 | $16M | +89% | 1.7M | 9.52 |
|
| Iqvia Holdings (IQV) | 1.5 | $15M | +146% | 87k | 170.54 |
|
| Agios Pharmaceuticals (AGIO) | 1.4 | $14M | +305% | 404k | 33.83 |
|
| Illumina (ILMN) | 1.4 | $14M | NEW | 110k | 123.26 |
|
| Edwards Lifesciences (EW) | 1.4 | $13M | +10% | 167k | 80.08 |
|
| Neurocrine Biosciences (NBIX) | 1.3 | $13M | -13% | 99k | 131.74 |
|
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 1.3 | $13M | -61% | 259k | 48.15 |
|
| Assembly Biosciences Com New (ASMB) | 1.2 | $11M | +64% | 411k | 27.75 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 1.2 | $11M | +321% | 232k | 48.20 |
|
| McKesson Corporation (MCK) | 1.1 | $11M | -65% | 13k | 865.36 |
|
| Stoke Therapeutics (STOK) | 1.1 | $11M | -21% | 337k | 32.56 |
|
| Miragen Therapeutics (VRDN) | 1.1 | $11M | -29% | 558k | 19.56 |
|
| Waystar Holding Corp (WAY) | 1.1 | $11M | +20% | 443k | 24.11 |
|
| Mineralys Therapeutics (MLYS) | 1.1 | $10M | -7% | 380k | 27.09 |
|
| Edgewise Therapeutics (EWTX) | 1.0 | $10M | -24% | 323k | 31.50 |
|
| Xeris Pharmaceuticals (XERS) | 1.0 | $10M | 1.7M | 5.80 |
|
|
| Tenet Healthcare Corp Com New (THC) | 1.0 | $9.5M | -17% | 50k | 188.71 |
|
| CryoLife (AORT) | 1.0 | $9.2M | +15% | 252k | 36.62 |
|
| Nuvalent Inc-a (NUVL) | 0.9 | $9.0M | -25% | 88k | 102.45 |
|
| Alphatec Hldgs Com New (ATEC) | 0.9 | $9.0M | +197% | 824k | 10.88 |
|
| Alnylam Pharmaceuticals (ALNY) | 0.9 | $8.9M | -43% | 27k | 330.87 |
|
| Axogen (AXGN) | 0.9 | $8.9M | +7% | 268k | 33.13 |
|
| Immunome (IMNM) | 0.9 | $8.8M | +45% | 404k | 21.87 |
|
| Amylyx Pharmaceuticals (AMLX) | 0.9 | $8.6M | +62% | 622k | 13.90 |
|
| IDEXX Laboratories (IDXX) | 0.9 | $8.4M | NEW | 15k | 561.89 |
|
| Waters Corporation (WAT) | 0.8 | $7.9M | -36% | 26k | 297.80 |
|
| Adaptive Biotechnologies Cor (ADPT) | 0.8 | $7.7M | +37% | 552k | 13.88 |
|
| Upstream Bio (UPB) | 0.7 | $7.1M | -5% | 787k | 9.00 |
|
| Erasca (ERAS) | 0.7 | $6.6M | NEW | 407k | 16.18 |
|
| Apogee Therapeutics (APGE) | 0.7 | $6.5M | -40% | 78k | 84.17 |
|
| Cooper Cos (COO) | 0.7 | $6.4M | -28% | 90k | 71.50 |
|
| Absci Corp (ABSI) | 0.6 | $5.6M | +27% | 1.9M | 3.00 |
|
| Tango Therapeutics (TNGX) | 0.6 | $5.6M | NEW | 266k | 20.92 |
|
| Moderna Put Put Option | 0.5 | $5.1M | NEW | 100k | 50.80 |
|
| Caredx (CDNA) | 0.5 | $5.1M | +5% | 291k | 17.36 |
|
| Urogen Pharma (URGN) | 0.5 | $4.9M | +62% | 275k | 17.98 |
|
| Ultragenyx Pharmaceutical (RARE) | 0.5 | $4.9M | +278% | 235k | 20.95 |
|
| 4d Molecular Therapeutics In (FDMT) | 0.5 | $4.9M | +3% | 523k | 9.31 |
|
| Irhythm Technologies (IRTC) | 0.5 | $4.7M | NEW | 40k | 118.02 |
|
| Minimed Group (MMED) | 0.5 | $4.7M | NEW | 317k | 14.92 |
|
| Si-bone (SIBN) | 0.5 | $4.7M | 374k | 12.63 |
|
|
| Carlsmed (CARL) | 0.5 | $4.7M | NEW | 521k | 9.05 |
|
| Optimizerx Corp Com New (OPRX) | 0.5 | $4.6M | +35% | 729k | 6.28 |
|
| Vir Biotechnology (VIR) | 0.5 | $4.5M | NEW | 500k | 8.96 |
|
| Supernus Pharmaceuticals (SUPN) | 0.5 | $4.4M | NEW | 85k | 51.69 |
|
| Caris Life Sciences (CAI) | 0.4 | $4.1M | +83% | 230k | 17.88 |
|
| CVRX (CVRX) | 0.4 | $4.1M | +3% | 430k | 9.46 |
|
| Inspiremd (NSPR) | 0.4 | $3.9M | 2.4M | 1.63 |
|
|
| Cogent Biosciences (COGT) | 0.4 | $3.9M | NEW | 100k | 38.49 |
|
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 0.4 | $3.7M | NEW | 301k | 12.43 |
|
| Annexon (ANNX) | 0.4 | $3.7M | +12% | 674k | 5.54 |
|
| Align Technology (ALGN) | 0.4 | $3.6M | -16% | 21k | 171.43 |
|
| Uniqure Nv SHS (QURE) | 0.3 | $3.4M | -19% | 207k | 16.35 |
|
| Genedx Holdings Corp Com Cl A (WGS) | 0.3 | $3.3M | +29% | 51k | 64.22 |
|
| Veracyte (VCYT) | 0.3 | $3.3M | 101k | 32.21 |
|
|
| Castle Biosciences (CSTL) | 0.3 | $3.1M | -16% | 126k | 24.55 |
|
| Compass Pathways Sponsored Ads (CMPS) | 0.3 | $3.1M | +457% | 554k | 5.53 |
|
| Bright Minds Biosciences Com New (DRUG) | 0.3 | $2.9M | NEW | 40k | 72.97 |
|
| Solid Biosciences Com New (SLDB) | 0.2 | $2.2M | -26% | 309k | 7.20 |
|
| Butterfly Network Com Cl A (BFLY) | 0.2 | $2.2M | +439% | 545k | 4.04 |
|
| Quidel Corp (QDEL) | 0.2 | $1.7M | -44% | 102k | 16.43 |
|
| Rxsight (RXST) | 0.2 | $1.5M | -28% | 250k | 6.16 |
|
| Quanterix Ord (QTRX) | 0.1 | $1.2M | +3% | 342k | 3.52 |
|
| Pulse Biosciences (PLSE) | 0.1 | $1.1M | NEW | 50k | 21.59 |
|
| Pulmonx Corp (LUNG) | 0.1 | $975k | +3% | 756k | 1.29 |
|
| Maze Therapeatics (MAZE) | 0.1 | $951k | -84% | 32k | 29.85 |
|
| Adma Biologics (ADMA) | 0.1 | $743k | -58% | 82k | 9.01 |
|
| Edap Tms S A Sponsored Adr (FOCL) | 0.1 | $576k | 155k | 3.72 |
|
|
| Ovid Therapeutics (OVID) | 0.0 | $462k | +3% | 208k | 2.22 |
|
| Accuray Incorporated (ARAY) | 0.0 | $343k | +3% | 885k | 0.39 |
|
| Entera Bio SHS (ENTX) | 0.0 | $320k | +4% | 289k | 1.11 |
|
Past Filings by Parkman Healthcare Partners
SEC 13F filings are viewable for Parkman Healthcare Partners going back to 2019
- Parkman Healthcare Partners 2026 Q1 filed May 15, 2026
- Parkman Healthcare Partners 2025 Q4 filed Feb. 17, 2026
- Parkman Healthcare Partners 2025 Q3 filed Nov. 14, 2025
- Parkman Healthcare Partners 2025 Q2 filed Aug. 14, 2025
- Parkman Healthcare Partners 2025 Q1 filed May 15, 2025
- Parkman Healthcare Partners 2024 Q4 filed Feb. 14, 2025
- Parkman Healthcare Partners 2024 Q3 filed Nov. 14, 2024
- Parkman Healthcare Partners 2024 Q2 filed Aug. 14, 2024
- Parkman Healthcare Partners 2024 Q1 filed May 15, 2024
- Parkman Healthcare Partners 2023 Q3 filed Nov. 14, 2023
- Parkman Healthcare Partners 2023 Q2 filed Aug. 11, 2023
- Parkman Healthcare Partners 2023 Q1 filed May 12, 2023
- Parkman Healthcare Partners 2022 Q4 filed Feb. 13, 2023
- Parkman Healthcare Partners 2022 Q3 filed Nov. 14, 2022
- Parkman Healthcare Partners 2022 Q2 filed Aug. 12, 2022
- Parkman Healthcare Partners 2022 Q1 filed May 13, 2022